(Q37994609)

26 August 2017

Clinical evidence of particle beam therapy (proton). (English)

1 reference

26 August 2017

Takashi Ogino

1

1 reference

26 August 2017

17 March 2012

1 reference

International Journal of Clinical Oncology

26 August 2017

1 reference

26 August 2017

17

1 reference

26 August 2017

2

1 reference

26 August 2017

79-84

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-012-0390-z

26 August 2017

0 references

cites work

Radiological Use of Fast Protons

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Development of a hospital-based proton beam treatment center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Particle radiation therapy using proton and heavier ion beams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton therapy in clinical practice: current clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton therapy - a systematic review of clinical effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Chordomas of the craniocervical junction: follow-up review and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Clinical results of proton beam therapy for skull base chordoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton radiation therapy for chordomas and chondrosarcomas of the skull base

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton therapy for tumors of the skull base

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton-beam therapy for olfactory neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Hypofractionated proton beam radiotherapy for stage I lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Clinical evaluation of proton radiotherapy for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

High-dose proton beam therapy for Stage I non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton therapy for prostate cancer: the initial Loma Linda University experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Conformal proton therapy for early-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Should randomized clinical trials be required for proton radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Significance and Implementation of RBE Variations in Proton Beam Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0390-Z

Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses

21 January 2018

1 reference

12 December 2020

Irradiation synchronized with respiration gate

1 reference

12 December 2020

Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis

1 reference

12 December 2020

Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma

1 reference

12 December 2020

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

1 reference

12 December 2020

Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy--dose-volume histogram analysis

1 reference

12 December 2020

Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East

1 reference

12 December 2020

Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience

1 reference

12 December 2020

Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan

1 reference

12 December 2020

Proton therapy for head and neck malignancies at Tsukuba

1 reference

12 December 2020

Is the risk for secondary cancers after proton therapy enhanced distal to the Planning Target Volume? A two-case report with possible explanations.

1 reference

12 December 2020

Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study

1 reference

12 December 2020

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

1 reference

12 December 2020

Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities

1 reference

12 December 2020

Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy

1 reference

12 December 2020

Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract

1 reference

12 December 2020

10.1007/S10147-012-0390-Z

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22426889